In particular, they showed that miR-152-3p is downmodulated in BC compared to normal tissues, and its reintroduction, or EPAS1 silencing, enhanced MCF-7/TAX cell sensitivity to paclitaxel. Here, EPAS1 is linked to breast cancer.